32 related articles for article (PubMed ID: 15929668)
1. Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma.
Wang CC; Lu DD; Shen MH; Chen RL; Zhang ZH; Lv JH
Diagn Pathol; 2023 Nov; 18(1):123. PubMed ID: 37951919
[TBL] [Abstract][Full Text] [Related]
2. Homogentisic acid metabolism inhibits papillary thyroid carcinoma proliferation through ROS and p21-induced cell cycle arrest.
Xie R; Lin J; Li W; Chen H; Zhang J; Zhong M; Xue J; Mo C; Chen L; Zhu Y; Chen X; Xu S
Life Sci; 2024 Jun; 347():122682. PubMed ID: 38702025
[TBL] [Abstract][Full Text] [Related]
3. Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia.
Bellelli R; Vitagliano D; Federico G; Marotta P; Tamburrino A; Salerno P; Paciello O; Papparella S; Knauf JA; Fagin JA; Refetoff S; Troncone G; Santoro M
Mol Cell Endocrinol; 2018 Jan; 460():24-35. PubMed ID: 28652169
[TBL] [Abstract][Full Text] [Related]
4. Effects of the Smad4 C324Y mutation on thyroid cell proliferation.
D'Inzeo S; Nicolussi A; Nardi F; Coppa A
Int J Oncol; 2013 Jun; 42(6):1890-6. PubMed ID: 23591524
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic markers in differentiated thyroid cancer.
Gómez Sáez JM
Curr Genomics; 2011 Dec; 12(8):597-608. PubMed ID: 22654559
[TBL] [Abstract][Full Text] [Related]
6. Expression of p21cip1, p27kip1, and p16INk4a cyclin-dependent kinase inhibitors in papillary thyroid carcinoma: correlation with clinicopathological factors.
Zafon C; Obiols G; Castellví J; Ramon y Cajal S; Baena JA; Mesa J
Endocr Pathol; 2008; 19(3):184-9. PubMed ID: 18766473
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-delta induces cell proliferation by a cyclin E1-dependent mechanism and is up-regulated in thyroid tumors.
Zeng L; Geng Y; Tretiakova M; Yu X; Sicinski P; Kroll TG
Cancer Res; 2008 Aug; 68(16):6578-86. PubMed ID: 18701481
[TBL] [Abstract][Full Text] [Related]
8. Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.
Pignataro L; Sambataro G; Pagani D; Pruneri G
Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):75-85. PubMed ID: 16116829
[TBL] [Abstract][Full Text] [Related]
9. Are p27 and p21 cytoplasmic oncoproteins?
Blagosklonny MV
Cell Cycle; 2002; 1(6):391-3. PubMed ID: 12548011
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of cyclins and cell cycle inhibitors in papillary thyroid cancer: prognostic implications.
Pickett CA; Agoff SN; Widman TJ; Bronner MP
Thyroid; 2005 May; 15(5):461-73. PubMed ID: 15929668
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.
Khoo ML; Beasley NJ; Ezzat S; Freeman JL; Asa SL
J Clin Endocrinol Metab; 2002 Apr; 87(4):1814-8. PubMed ID: 11932323
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
